GnRH agonist plus vaginal progesterone for luteal phase support in ICSI cycles: A randomized study

Reproductive BioMedicine Online

Volumn 30, Issue 1, 2015, Pages 52-56

  Aboulghar, Mohamed A ^a,b   Marie, Heba ^a,b   Amin, Yahia M ^b   Aboulghar, Mona M ^a,b   Nasr, Ahmed ^c   Serour, Gamal I ^b   Mansour, Ragaa T ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b Egyptian IVF Center   (Egypt)

^c Assiut University Faculty of Medicine   (Egypt)

Author keywords

clinical pregnancy rate; GnRHa; IVF ICSI; luteal phase; randomized study

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRADIOL; GONADORELIN AGONIST; PROGESTERONE; GONADORELIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; MAJOR CLINICAL STUDY; OOCYTE RETRIEVAL; PREGNANCY RATE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SUPPOSITORY; TREATMENT OUTCOME; AGONISTS; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; INFERTILITY THERAPY; METABOLISM; OOCYTE; PREGNANCY; PROCEDURES; VAGINA; YOUNG ADULT;

ADULT; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEAL PHASE; OOCYTES; PREGNANCY; PREGNANCY RATE; PROGESTERONE; REPRODUCTIVE TECHNIQUES, ASSISTED; SPERM INJECTIONS, INTRACYTOPLASMIC; VAGINA; YOUNG ADULT;

EID: 84920152856     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2014.09.017     Document Type: Article

References (25)

1. Aboulghar M.A., Mansour R.T., Serour G.I., and Amin Y.M. The prognostic value of successful in vitro fertilization in subsequent trials Hum. Reprod 9 1994 1932 1934
2. Ata B., Yakin K., Balaban B., and Urman B. GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonist protocol: a randomized, controlled double blind study Hum. Reprod 23 2008 668 673
3. Beckers N.G., Macklon N.S., Eijkemans M.J., Ludwig M., Felberbaum R.E., Diedrich K., Bustion S., Loumaye E., and Fauser B.C. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment J. Clin. Endocrinol. Metab 88 2003 4186 4192
4. Casper R.F., and Yen S.S. Induction of luteolysis in the human with a long-acting analog of luteinizing hormone-releasing factor Science 205 1979 408 479
5. Cedrin-Durnerin I., Bidart J.M., Robert P., Wolf J.P., Uzan M., and Hugues J.N. Consequences on gonadotrophin secretion of an early discontinuation of gonadotrophin-releasing hormone agonist administration in short-term protocol for in-vitro fertilization Hum. Reprod 15 2000 1009 1014
6. Daya S., and Gunby J. Luteal phase support in assisted reproduction cycles Cochrane Database Syst. Rev 2004 CD004830
7. Fauser B.C., and Devroey P. Reproductive biology and IVF: ovarian stimulation and luteal phase consequences Trends Endocrinol. Metab 14 2003 236 242
8. Fujii S., Sagara M., Kudo H.A., Kagiya A., Sato S., and Saito Y. A prospective randomized comparison between long and discontinuous-long protocols of gonadotropin-releasing hormone agonist for in vitro fertilization Fertil. Steril 67 1997 1166 1168
9. Fujii S., Sato S., Fukui A., Kimura H., Kasai G., and Saito Y. Continuous administration of gonadotrophin-releasing hormone agonist during the luteal phase in IVF Hum. Reprod 16 2001 1671 1675
10. Geber S., and Sampaio M. Effect of duration of the GnRH agonists in the luteal phase in the outcome of assisted reproduction cycles Gynecol. Endocrinol 29 2013 608 610
11. Inamdar D.B., and Majumdar A. Evaluation of the impact of gonadotropin-releasing hormone agonist as an adjuvant in luteal-phase support on IVF outcome J. Hum. Reprod. Sci 5 2012 279 284
12. Jee B.C., Suh C.S., Kim S.H., Kim Y.B., and Moon S.Y. Effects of estradiol supplementation during the luteal phase of in vitro fertilization cycles: a meta-analysis Fertil. Steril 93 2010 428 436
13. Kyrou D., Kolibianakis E.M., Fatemi H.M., Tarlatzi T.B., Devroey P., and Tarlatzis B.C. Increased live birth rates with GnRH agonist addition for luteal support in ICSI/IVF cycles: a systematic review and meta-analysis Hum. Reprod. Update 17 2011 734 740
14. Lemay A., Labrie F., Belander A., and Raynaud J.P. Luteolytic effect of intranasal administration of (D-Ser(TBU)6, des-Gly-NH210)-luteinizing hormone-releasing hormone ethylamide in normal women Hum. Reprod 7 1992 465 468
15. Macklon N.S., and Fauser B.C. Impact of ovarian hyperstimulation on the luteal phase J. Reprod. Fertil 55 2000 101 108
16. Nam D.H., Lee S.H., Kim H.S., Lee G.S., Jeong Y.W., Kim S., Kim J.H., Kang S.K., Lee B.C., and Hwang W.S. The role of gonadotropin-releasing hormone (GnRH) and its receptor in development of porcine preimplantation embryos derived from in vitro fertilization Theriogenology 63 2005 190 201
17. Oppenheimer D., Bikkai H., and Crowley W. Effects of chorionic GnRH analogue administration on gonadotrophin and alpha subunit secretion in post-menopausal women Clin. Endocrinol 36 1992 559 564
18. Pirard C., Donnez J., and Loumaye E. GnRH agonist as novel luteal support: results of a randomized, parallel group, feasibility study using intranasal administration of buserelin Hum. Reprod 20 2005 1798 1804
19. Pritts E.A., and Atwood A.K. Luteal phase support in infertility treatment: a meta-analysis of the randomized trial Hum. Reprod 17 2002 2287 2299
20. Raga F., Casan E.M., Kruessel J., Wen Y., Bonilla-Musoles F., and Polan M.L. The role of gonadotropin-releasing hormone in murine preimplantation embryonic development Endocrinology 140 1999 3705 3712
21. Sheehan K.L., Casper R.F., and Yen S.S. Luteal phase defects induced by an agonist of luteinizing hormone-releasing factor: a model for fertility control Science 215 1982 170 172
22. Takeuchi S., Futamura N., Minoura H., and Toyoda N. Possible direct effect of gonadotropin releasing hormone on human endometrium and decidua Life Sci 62 1998 1187 1194
23. Tesarik J., Hazout A., and Mendoza C. Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation Hum. Reprod 19 2004 1176 1180
24. Tesarik J., Hazout A., Mendoza-Tesarik R., Mendoza N., and Mendoza C. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist-and antagonist-treated ovarian stimulation cycles Hum. Reprod 21 2006 2572 2579
25. Winslow K.L., Gordon K., Williams R.F., and Hodgen G.D. Interval required for gonadotropin0releasing hormone-agonist-induced down regulation of the pituitary in cynomolgus monekeys and duration of the refractory state Fertil. Steril 58 1992 1209 1214